- Home
- ADAML vs CNTA Comparison
ADAML vs CNTA Comparison
Compare ADAML & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAML
- CNTA
- Stock Information
- Founded
- ADAML N/A
- CNTA 2020
- Country
- ADAML United States
- CNTA United Kingdom
- Employees
- ADAML N/A
- CNTA N/A
- Industry
- ADAML Real Estate Investment Trusts
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- ADAML Real Estate
- CNTA Health Care
- Exchange
- ADAML Nasdaq
- CNTA Nasdaq
- Market Cap
- ADAML 2.0B
- CNTA 2.3B
- IPO Year
- ADAML N/A
- CNTA 2021
- Fundamental
- Price
- ADAML $22.45
- CNTA $21.81
- Analyst Decision
- ADAML
- CNTA Strong Buy
- Analyst Count
- ADAML 0
- CNTA 11
- Target Price
- ADAML N/A
- CNTA $30.60
- AVG Volume (30 Days)
- ADAML N/A
- CNTA 1.5M
- Earning Date
- ADAML N/A
- CNTA 11-11-2025
- Dividend Yield
- ADAML N/A
- CNTA N/A
- EPS Growth
- ADAML N/A
- CNTA N/A
- EPS
- ADAML N/A
- CNTA N/A
- Revenue
- ADAML N/A
- CNTA $15,000,000.00
- Revenue This Year
- ADAML N/A
- CNTA N/A
- Revenue Next Year
- ADAML N/A
- CNTA N/A
- P/E Ratio
- ADAML N/A
- CNTA N/A
- Revenue Growth
- ADAML N/A
- CNTA 118.88
- 52 Week Low
- ADAML N/A
- CNTA $9.60
- 52 Week High
- ADAML N/A
- CNTA $23.24
- Technical
- Relative Strength Index (RSI)
- ADAML N/A
- CNTA 71.02
- Support Level
- ADAML N/A
- CNTA $15.01
- Resistance Level
- ADAML N/A
- CNTA $23.24
- Average True Range (ATR)
- ADAML 0.00
- CNTA 1.23
- MACD
- ADAML 0.00
- CNTA 0.59
- Stochastic Oscillator
- ADAML 0.00
- CNTA 82.62
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.